Valuation: Cencora, Inc.

Market Cap 66.67B 375B 60.29B 55.65B 50.37B 95.06B 6,268B 97.91B 668B 265B 3,351B 250B 245B 10,665B P/E 2026
16.7x
P/E 2027 * 20.8x
Enterprise Value 74.09B 416B 67B 61.84B 55.98B 106B 6,965B 109B 742B 295B 3,724B 278B 272B 11,852B EV / Sales 2026
0.17x
EV / Sales 2027 * 0.2x
Free-Float
61.21%
Yield 2026 *
0.68%
Yield 2027 * 0.71%
1 day-5.21%
3 months+9.72%
6 months+2.00%
Current year-18.34%
Current year 665.32
Extreme 665.32
952.48
1 year 665.32
Extreme 665.32
958.91
3 years 490.78
Extreme 490.78
960
5 years 328.35
Extreme 328.35
960
10 years 181.9
Extreme 181.9
960
Manager TitleAgeSince
Chief Executive Officer 59 2024-09-30
Director of Finance/CFO 59 2026-06-28
Chief Tech/Sci/R&D Officer 50 2024-11-03
Director TitleAgeSince
Director/Board Member 75 2013-05-15
Director/Board Member 59 2024-09-30
Chairman 64 2025-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-5.21%-.--% - - 66.67B
-1.87%-5.59%-16.74%+14.13% 186B
-0.61%-3.67%+5.41%+42.88% 124B
-2.01%-6.77%-14.96%+14.17% 119B
+1.11%-6.17%-43.15%+2.88% 91.43B
-0.14%+2.86%-3.86%+76.84% 66.67B
+0.55%+1.01%+12.28%-8.07% 58.76B
-0.65%+4.07%-2.18%+62.81% 54.99B
-0.68%+6.83%-1.64%+55.26% 49.93B
-5.17%+0.55% - - 35.13B
Average -1.26%-1.98%-8.11%+32.61% 87B
Weighted average by Cap. -0.89%-3.37%-10.54%+27.65%

Financials

2026 2027 *
Net sales 337B 1,895B 305B 281B 255B 481B 31,684B 495B 3,377B 1,342B 16,938B 1,265B 1,238B 53,914B 352B 1,979B 318B 294B 266B 502B 33,104B 517B 3,528B 1,402B 17,697B 1,322B 1,293B 56,331B
Net income 3.58B 20.13B 3.24B 2.99B 2.71B 5.1B 337B 5.26B 35.87B 14.26B 180B 13.44B 13.15B 573B 3.16B 17.76B 2.86B 2.64B 2.39B 4.5B 297B 4.64B 31.65B 12.58B 159B 11.86B 11.6B 505B
Net Debt 7.42B 41.7B 6.71B 6.19B 5.61B 10.58B 697B 10.89B 74.33B 29.54B 373B 27.84B 27.25B 1,187B 3.71B 20.87B 3.36B 3.1B 2.81B 5.29B 349B 5.45B 37.2B 14.78B 187B 13.94B 13.64B 594B
Projected Income Statement - Annual - Cencora, Inc.
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Cencora, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
349.38USD
Average target price
381.25USD
Spread / Average Target
+9.12%